MedPath

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center logo
🇺🇸United States
Ownership
Private
Established
1884-01-01
Employees
10K
Market Cap
-
Website
http://www.mskcc.org

Imaging With a New Agent That Finds a Cancer Protein Called HER2

Phase 1
Completed
Conditions
HER2-positive Carcinoma
HER2-positive Primary Malignancy
Interventions
Drug: Zr-DFO-pertuzumab PET/CT
First Posted Date
2017-04-12
Last Posted Date
2018-04-17
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
6
Registration Number
NCT03109977
Locations
🇺🇸

Memorial Slaon-Kettering Cancer Center, New York, New York, United States

Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells

Phase 1
Active, not recruiting
Conditions
Unresectable Hepatocellular Carcinoma
Interventions
Procedure: Hepatic artery embolization (HAE)
First Posted Date
2017-04-11
Last Posted Date
2025-05-01
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
30
Registration Number
NCT03107416
Locations
🇺🇸

Memorial Sloan Kettering Westchester (Consent and follow-up only), Harrison, New York, United States

🇺🇸

Memorial Sloan Kettering Basking Ridge (Consent and follow-up only), Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Monmouth (Consent and follow-up only), Middletown, New Jersey, United States

and more 2 locations

Adaptive Radiotherapy for Head and Neck Cancer

Phase 2
Completed
Conditions
Head and Neck Cancer
Paranasal Sinus Cancer
Nasopharynx Cancer
Hypopharynx Cancer
Oropharynx Cancer
Oral Cavity Cancer
Larynx Cancer
Interventions
Radiation: Adaptive Radiotherapy
First Posted Date
2017-03-30
Last Posted Date
2021-10-26
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
64
Registration Number
NCT03096808
Locations
🇺🇸

Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 5 locations

A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

Phase 2
Active, not recruiting
Conditions
Urothelial Carcinoma
Locally Advanced
Unresectable
Interventions
First Posted Date
2017-03-28
Last Posted Date
2025-04-22
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
32
Registration Number
NCT03093922
Locations
🇺🇸

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

🇺🇸

Ohio State University, Columbus, Ohio, United States

🇺🇸

Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 6 locations

Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer

Early Phase 1
Active, not recruiting
Conditions
Anaplastic Thyroid Cancer
Interventions
First Posted Date
2017-03-21
Last Posted Date
2024-07-03
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
13
Registration Number
NCT03085056
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities), Commack, New York, United States

and more 4 locations

A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies

Phase 1
Active, not recruiting
Conditions
Refractory
Relapsed
Chronic Lymphocytic Leukemia (CLL)
Interventions
Biological: EGFRt/19-28z/4-1BBL CAR T cells
First Posted Date
2017-03-21
Last Posted Date
2025-04-02
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
39
Registration Number
NCT03085173
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Dye for the Detection of Cancer of the Tongue and Mouth

Phase 1
Active, not recruiting
Conditions
Oral Squamous Cell Carcinoma (OSCC)
Interventions
First Posted Date
2017-03-21
Last Posted Date
2025-02-11
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
23
Registration Number
NCT03085147
Locations
🇺🇸

Memorial Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Westchester (Consent Only), Harrison, New York, United States

and more 4 locations

Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies

Phase 2
Completed
Conditions
Myeloid Hematologic Malignancy
Lymphoid Hematologic Malignancy
Interventions
First Posted Date
2017-03-17
Last Posted Date
2022-09-27
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
20
Registration Number
NCT03082677
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Risk Stratification Among Individuals Who Have Many Moles on Their Skin

Active, not recruiting
Conditions
High-Risk Nevus Phenotype
Interventions
Behavioral: survey
Other: Saliva samples
First Posted Date
2017-03-15
Last Posted Date
2025-04-02
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
73
Registration Number
NCT03080948
Locations
🇺🇸

Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

Memorial Sloan Kettering Westchester, Harrison, New York, United States

and more 1 locations

Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant

Phase 2
Active, not recruiting
Conditions
Intestinal Microbiome
Febrile Neutropenia
Interventions
First Posted Date
2017-03-13
Last Posted Date
2025-03-04
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
347
Registration Number
NCT03078010
Locations
🇺🇸

Hackensack Meridian Health, Hackensack, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath